metoclopramide has been researched along with Bright Disease in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuoka, H | 1 |
| Fukui, K | 1 |
| Dan, Y | 1 |
| Ishimitsu, T | 1 |
| Hirata, Y | 1 |
| Kimura, K | 1 |
| Sugimoto, T | 1 |
| Ishii, M | 1 |
| Kangawa, K | 1 |
| Matsuo, H | 1 |
1 trial available for metoclopramide and Bright Disease
| Article | Year |
|---|---|
Atrial natriuretic peptide inhibits the aldosterone response to metoclopramide in patients with glomerular disease and essential hypertension.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerulonephritis; Heart Rat | 1991 |